Position in ERAS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$114,741,392
+$73,614,732 QoQ
Shares Held
7,091,557
-35.9% QoQ
Ownership
2.28%
of shares outstanding
% of Portfolio
16.95%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ARCH Venture Management, LLC holds $672,473,115 across 9 Biotechnology names. ERAS ranks #4 (17.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MAZE |
Maze Therapeutics, Inc.
|
4,120,053 | $122,983,582 | |
| 2 | RAPP |
Rapport Therapeutics, Inc.
|
3,728,738 | $116,672,212 | |
| 3 | VIR |
Vir Biotechnology, Inc.
|
12,916,663 | $115,733,300 | |
| 4 | ERAS |
Erasca, Inc.
This page
|
7,091,557 | $114,741,392 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
4,540,132 | $108,191,345 | |
| 6 | LYEL |
Lyell Immunopharma, Inc.
|
3,247,162 | $65,138,069 | |
| 7 | GENB |
Generate Biomedicines, Inc.
|
1,944,426 | $24,305,325 | |
| 8 | GOSS |
Gossamer Bio, Inc.
|
8,055,916 | $2,650,396 |
All Filings in ERAS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $114,741,392 | 7,091,557 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $41,126,660 | 11,055,554 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $24,101,107 | 11,055,554 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,040,553 | 11,055,554 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,146,108 | 11,055,554 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $27,749,440 | 11,055,554 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $30,181,662 | 11,055,554 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $26,091,107 | 11,055,554 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $22,774,441 | 11,055,554 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $23,548,330 | 11,055,554 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $21,779,441 | 11,055,554 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $30,513,329 | 11,055,554 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $33,277,217 | 11,055,554 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $47,649,437 | 11,055,554 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $86,233,321 | 11,055,554 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $61,579,435 | 11,055,554 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $95,077,764 | 11,055,554 | Shares | Sole | 2022-05-27 | |
| 2021-12-31 | $172,245,531 | 11,055,554 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||